期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

缺血性脑血管病的抗凝治疗 被引量：12

Anticoagulantion of Ischemic Cerebrovascular Diseases
原文传递
导出
摘要 抗凝是预防和治疗缺血性脑血管病的重要手段之一,在临床已经应用了60余年。文章通过介绍近20年(特别是近10年)来国际上进行的一系列有重要影响的大规模随机对照临床试验,就抗凝在缺血性脑血管病中的应用进展做了综述。 Anticoagulation, which has been used in clinical practice since 1940＇s, is one of the important measures in the prevention and treatment of cerebrovascular diseases. This article reviews the progress in anticoagulation for ischemic cerebrovascular diseases by introducing a series of large, important, international, randomized controlled clinical trials in the past 20 years （particularly in the recent 10 years）.
作者 徐安定 周高枫
机构地区 暨南大学附属第一医院神经内科
出处 《国际脑血管病杂志》 2006年第4期241-246,共6页 International Journal of Cerebrovascular Diseases
关键词 抗凝 缺血性脑血管病 预防 治疗 anticoagulation ischemic cerebrowascular disease prevention treatment
分类号 R743.3 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献43

  • 1Hedenius P.The use of heparin in internal diseases.Acta Med Scand,1941,107:170-177.
  • 2曹茂红,柯开富.抗栓治疗在急性脑梗死治疗中的应用和评价[J].国外医学（脑血管疾病分册）,2003,11(6):429-431. 被引量：31
  • 3许俊堂,胡大一.低分子肝素的抗凝优势[J].中国处方药,2003,2(9):31-35. 被引量：3
  • 4Duke R J,Bolch RF,Turpie AG,et al.Intravenous heparin for prevention of stroke progression in acute partial stable stroke.Ann Int Med,1986,105:825-828.
  • 5Adams HP Jr.Emergent use of anticoagulation for treatment of patients with ischemic stroke.Stroke,2002,33:856-861.
  • 6Berge E,Abdelnoor M,Nakstad PH,et al.Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation:a double-blind randomised study.HAEST Study Group.Heparn in Acute Embolic Stroke Trial.Lancet,2000,355:1205-1210.
  • 7Gubitz G,Sandercock P,Counsell C.Anticoagulants for acute ischaemic stroke.Cochrane Database Syst Rev,2004,(3):CD000024.
  • 8Sandercock P,Counsell C,Stobbs SL.Low-molecular-weight heparns or heparnoids versus standard unfractionated heparin for acute ischaemic stroke.Cochrane Database Syst Rev,2005,(2):CD000119.
  • 9Kay R,Wong KS,Yu YL,et al.Low-molecular-weight heparin for the treatment of acute ischemic stroke.N Engl J Med,1995,333:1588-1593.
  • 10The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.Low molecular weight heparnoid,ORG 10172 (danaparoid),and outcome after acute ischemicstroke:a randomized controlled trial.JAMA,1998,279:1265-1272.

二级参考文献31

  • 1刘译霖 贺石林 等.血栓性疾病的诊断与治疗[M].北京:人民卫生出版社,2000.328-329.
  • 2Hill MD, I-Iachnaski V. Stroke treatment: tkne is brain. Lancet, 1998,352(Sulalal 3): SIII10 - SIII14.
  • 3Vackenbottom SL, Barsan WG. Acute ischemic stroke therapy. Neurol Clin, 2000, 18:379 -397.
  • 4Reiaer AP, Kumar PN, Schwartz SM, et al. Genetic variants of platelet glycoprotena receptors and risk of stroke na young women. Stroke,2000, 31 : 1628 - 1633.
  • 5Sonoda A, Murata M, Ito D, et al. Association between platelet glycoproteio Ibaipha genotype and ischemic cerebrovascular disease.Stroke, 2000, 31:493 -497.
  • 6pasche B, Ouknet H, Francis S, et al. Structural changes in platelet glycoprotena IIb/IIIa by ptasmin: determhants and fimctional consequences. Blood, 1994, 83:404 -414.
  • 7Bonnefoy A, Hantgan R, Legrand C, et al. A model of platelet aggregation iavolving multiple nateractions of thrombospondha-1, fibrinogen,and GPIIbIIIa receptor. J Biol Chem, 2001,276:5605 -5612.
  • 8Belniak-Legiec E, Steknasiak Z. Blood platelet activation markers in patients with acute cerebral infarction during the earliest stage of the disease-evaluation usnag flow cytometry methods. Neurol Neurochir Pol, 2000, 34:853 -864.
  • 9Wang C, Mody M, Herst R. Flow cytometric analysis of platelet function m stored platelet concentrates. Transfus Sci, 1999, 20:129 - 139.
  • 10Llinas R, Caplan LR. Evidence-based treatment of patients with ischemic cerebrovascular disease. Nenrol Clkt, 2001, 19:79 - 105.

共引文献1429

同被引文献66

引证文献12

二级引证文献70

国际脑血管病杂志
2006年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部